Powles T, et al. A phase II study investigating the safety and efficacy of savolitinib and durvalumab in metastatic papillary renal cancer (CALYPSO). ASCO-GU 2019, abstract 545.
Toevoeging metformine verbetert invasieve ziektevrije overleving bij borstkanker niet
aug 2022 | Borstkanker